Clinical

Mylan Pharmaceutical may be getting some competition for its EpiPen, as Israel-based Teva Pharmaceutical Industries announced Friday that it hopes to launch its own generic version of the device by 2018 in the U.S.

Cerner has opened Healthe at Cerner Center at its Manyata campus in Bangalore, India – giving more than 2,200 associates access to the clinic, which offers routine screenings, physical exams and more.

AAP will put the funds toward technical assistance and education for clinicians and community health centers dealing with people infected with the virus.

By combining Dragon Medical and Imprivata Cortext, the companies can offer a speaker-adaptive engine, custom vocabularies, built-in visualization, voice navigation and other features.

The $8.2 million deal with Moderna aims to accelerate the development of vaccine technology and is expected to be faster than other approaches in developing vaccines.

These approaches have enormous potential to enable clinicians, doctors and researchers to spot patterns in existing data sets. We take a look at the two styles and what they mean to healthcare organizations.

The funding will help speed the development of a new test that uses digital images of a biopsy slide to detect Barrett’s Esophagus, a condition that can lead to cancer, the companies said.

A team at Houston Methodist believes it has developed an artificial intelligence software program that can improve mammography readings to 99 percent accuracy by analyzing the free form text of clinical reports.

The FDA has approved more generics the past few years, but a flood of new applications has steadily added to the demand. And critics say getting generic alternatives to the U.S. market for products like EpiPen is still taking far too long.

The U.S. Department of Health and Human Services said that if the work advances and is approved quickly clinical trials could begin in the U.S. next year.